Raven Industries, Inc.
Raven Industries, Inc. (RAVN) relating to its proposed acquisition by CNH Industrial N.V. RAVN shareholders will receive $58.00 in cash per share they own.
Raven Industries, Inc. (RAVN) relating to its proposed acquisition by CNH Industrial N.V. RAVN shareholders will receive $58.00 in cash per share they own.
New Senior Investment Group, Inc. (SNR) relating to its proposed merger with Ventas, Inc. SNR shareholders will receive 0.1561 shares of Ventas per share they own.
County Bancorp, Inc. (ICBK) relating to its proposed acquisition by Nicolet Bancshares, Inc. (NCBS) Under the terms of the agreement, ICBK shareholders will receive either 0.48 shares of NCBS or $37.18 in cash per share they own.
IKONICS Corp. (IKNX) relating to its proposed acquisition by TeraWulf, Inc. Under the terms of the agreement, IKNX shareholders will receive $5.00 in cash, one contingent value right, and one share of the newly combined company per share they own.
SharpSpring, Inc. (SHSP) relating to its proposed acquisition by Constant Contact. Under the terms of the agreement, SHSP shareholders will receive $17.10 in cash per share they own.
Sykes Enterprises, Inc. (SYKE) relating to its proposed acquisition by Sitel Group. Under the terms of the agreement, SYKE shareholders will receive $54.00 in cash per share they own.
CAI International, Inc. (CAI) relating to its proposed acquisition by Mitsubishi HC Capital, Inc. Under the terms of the agreement, CAI shareholders will receive $56.00 in cash per share they own.
Bank of Commerce Holdings (BOCH) relating to its proposed acquisition by Columbia Banking System, Inc. (COLB) Under the terms of the agreement, BOCH shareholders will receive 0.40 shares of COLB per share they own.
Cortland Bancorp, Inc. (CLDB) relating to its proposed acquisition by Farmers National Banc Corp. Under the terms of the agreement, CLDB shareholders will receive either 1.75 shares of FMNB or $28.00 in cash per share they own.
Rafael Holdings, Inc. (RFL) relating to its proposed merger with Rafael Pharmaceuticals, Inc.